A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2018; you can also visit the original URL.
The file type is application/pdf.
New Rhenium Radiopharmaceuticals for the Selective Imaging and Therapy of Breast Cancer
[report]
1999
unpublished
Preserved Fulltext
Public reporting burden for this collection of Information It estimated to average 1 hour per response, Including the time for reviewing Instructions, searching existing data sources, gsthering and maintaining the data needed, and completing and reviewing the collection of information. Send comments regarding this burden estimate or any other aspect of this collection of Information, Including suggestions for reducing this burden, to Washington Headquarter« Services, Directorate for Information
doi:10.21236/ada373946
fatcat:fw23grqjfjfrdjotksv2dqdxqm